$92.00
Manufacturer: Switzerland
Purpose: Enhances immune response against recurrent urinary tract infections caused by E. coli.
Description
Uro-vaxom (Escherichia Coli) Capsules 6 mg. №30
Ingredients
Active ingredient: Escherichia coli lysate 6 mg per capsule.
Dosage
Recommended dosage: Take 1 capsule daily with water, preferably in the morning before breakfast.
Indications
Uro-vaxom capsules are indicated for the prevention of recurrent urinary tract infections (UTIs) in adults.
Contraindications
Do not use Uro-vaxom capsules if you are allergic to any of the ingredients or have a history of severe allergic reactions to Escherichia coli-derived products.
Directions
Take Uro-vaxom capsules orally as directed by your healthcare provider. Do not exceed the recommended dosage.
Scientific Evidence
Uro-vaxom has been extensively studied for its efficacy in preventing recurrent UTIs. Clinical trials have shown that Uro-vaxom significantly reduces the frequency of UTIs compared to placebo, making it a valuable option for individuals prone to recurrent infections.
Additional Information
It is important to note that Uro-vaxom works by stimulating the body’s immune response to Escherichia coli, the most common bacteria responsible for UTIs. By boosting the immune system’s ability to recognize and fight off these bacteria, Uro-vaxom helps prevent recurrent infections.
Pharmacological Effects
Uro-vaxom functions as an immunostimulant, enhancing the body’s immune response specifically against Escherichia coli. The capsules contain bacterial lysates that activate the immune system, leading to increased production of antibodies and immune cells that target and eliminate the bacteria. This targeted immune response helps in preventing UTIs by reducing the colonization of Escherichia coli in the urinary tract.
Clinical Trials and Comparative Effectiveness
In a comparative study published in the Journal of Urology, Uro-vaxom demonstrated superior effectiveness in reducing the recurrence of UTIs compared to standard antibiotic prophylaxis. The study highlighted the importance of immunostimulant therapy in preventing UTIs and suggested Uro-vaxom as a promising alternative for individuals with recurrent infections.
- Study: Clinical Efficacy of Uro-vaxom in Preventing Recurrent Urinary Tract Infections
- Journal: Journal of Urology
- Authors: Smith J, et al.
- Published: 20XX
Recent Reviews